Heart Failure and Osteoporosis: Shared Challenges in the Aging Population

Area of Science:

• Geriatric Medicine
• Cardiology
• Endocrinology

Background:

• Heart failure (HF) and osteoporosis (OP) are frequently comorbid, particularly in individuals over 50.
• The co-occurrence of HF and OP leads to poorer patient prognosis compared to either condition alone.
• Clinical evidence suggests a bidirectional relationship, where fractures increase HF risk and HF increases fracture risk.

Purpose of the Study:

• To review the common pathophysiological mechanisms linking heart failure and osteoporosis.
• To identify potential new therapeutic targets for managing these intertwined conditions.

Main Methods:

• Literature review of clinical studies and pathophysiological mechanisms.
• Analysis of shared pathways involving vitamin D, parathyroid hormone (PTH), and Fibroblast Growth Factor 23 (FGF-23).
• Examination of factors contributing to OP in HF patients and vice versa.

Main Results:

• Osteoporosis patients are prone to HF due to vitamin D deficiency, elevated PTH, and increased FGF-23.
• HF patients are susceptible to OP and fractures from low vitamin D, high PTH, renal failure, and hormonal/medication effects.
• Shared mechanisms include vitamin D deficiency, PTH dysregulation, and FGF-23 activity.

Conclusions:

• The interplay between HF and OP involves complex, shared pathophysiological pathways.
• An integrated clinical approach focusing on early diagnosis and treatment is crucial for improving patient outcomes.
• Understanding these common mechanisms may reveal novel therapeutic strategies for both conditions.